Dreampath Diagnostics
J.R. Nieman is a seasoned sales professional with a strong background in business administration. With experience in various companies such as Dreampath Diagnostics, Oaktree Investments, and Thermo Fisher Scientific, J.R. has held positions ranging from CEO/Owner to National Sales Director. J.R. has a Bachelor's Degree in Business Administration from North Carolina State University and furthered their education with a focus on Leadership Development, Business, Management, Marketing, and Related Support Services at the University of North Carolina at Chapel Hill.
This person is not in any offices
Dreampath Diagnostics
Industry leaders in patient sample management and traceability. Improving patient safety and AP lab workflow by advancing sample chain-of-custody. #patientsafety The Dreampath portfolio is built upon: -The importance patient safety and advancing it through proper chain-of-custody for patient samples in the anatomic pathology (AP) lab -The need for robust, reliable, and accurate access to samples in the AP lab (both clinical and research environments) -Fina, Crystal and Hydra track and monitor patient samples in the laboratory workflow, from receipt to diagnosis www.dreampathdx.net YouTube: @DreampathDiagnostics Twitter: @DreampathDx